Abellas et al. 2017 | Azzalini et al. 2016 | Fam et al. 2017 | Goktekin et al. 2015 | Kugler et al. 2017 | Lesiak et al. 2016 | Mitomo et al. 2016 | Ojeda et al. 2015 | Ozel et al. 2016 | Saad et al. 2016 | Vaquerizo et al. 2016 | Wiebe et al. 2015 | Yamac et al. 2017 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Age (years) | 59.2 ± 8.7 | 60.0 ± 9.3 | 59.40 ± 8.96 | 56.9 ± 9.4 | 60.5 ± 7.8 | 59.9 ± 8.3 | 60.8 ± 11.0 | 58 ± 9 | 61.9 ± 9.7 | 65.3 ± 10.9 | 61 ± 10 | 60.4 ± 9.0 | 57.8 ± 9.6 |
Male (%) | – | 89.5 | 89.5 | 90.0 | 85.7 | 77.5 | 89.2 | 98 | 85.4 | 75 | 80 | 81.8 | 86.7 |
Hypertension (%) | 44.4 | 65.4 | 69.5 | 78.6 | 64.3 | 80 | 67.8 | 57 | 80.5 | 78.6 | – | 91.3 | 80 |
Diabetes (%) | 22.2 | 34.0 | 33.3 | 21.4 | 14.3 | 30 | 40 | 33 | 51.2 | 26.3 | 20 | 34.8 | 3.3 |
Smoking (%) | 77.8 | 24.8 | 48.6 | 35.7 | 57.1 | 35 | – | 8 | 34.1 | 41.5 | – | 47.8 | 40 |
Family History (%) | – | 29.6 | 21.9 | 32.9 | – | – | – | – | – | 30.8 | – | – | 33.3 |
Hyperlipidemia (%) | 100 | 69.9 | 72.4 | 52.9 | 71.4 | – | 61.5 | 64 | 46.3 | 50.4 | – | 65.2 | 56.7 |
Prior CABG (%) | – | 2.6 | 2.9 | 10 | 0 | 5 | 6.2 | – | 17.1 | 2.7 | – | – | 6.7 |
Prior PCI (%) | – | 43.8 | 46.7 | 17.1 | – | 45 | 53.8 | 36 | 56.1 | 39.3 | – | – | 13.3 |
Prior stroke/TIA (%) | 0 | 2.6 | – | 0 | – | – | 30.8 | – | – | – | – | – | 0 |
CKD (%) | – | 5.5 | – | 2 | 7.1 | 15 | 40.1 | – | 0 | – | – | – | 0 |
LVEF (%) | – | 53.2 ± 10.1 | – | 51.7 ± 6.7 | – | 50.7 ± 10.2 | 57.7 ± 10.8 | 54 ± 8 | – | 59.8 ± 13.8 | – | 55.7 ± 15.5 | 50.2 ± 6.4 |